Publicaciones (75) Publicaciones de José María Hermida Santos

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

2019

  1. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    TH Open

  2. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809

2018

  1. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study

    PLoS ONE, Vol. 13, Núm. 8

2017

  1. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

    Journal of Hematology and Oncology, Vol. 10, Núm. 1, pp. 1-12

  2. Inducing heat shock protein 70 expression provides a robust antithrombotic effect with minimal bleeding risk

    Thrombosis and Haemostasis, Vol. 117, Núm. 9, pp. 1722-1729

2016

  1. Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk

    Cardiovascular Research, Vol. 110, Núm. 3, pp. 309-318

  2. Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

    European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136

  3. Short Leukocyte Telomere Length Is Associated with Cardioembolic Stroke Risk in Patients with Atrial Fibrillation

    Stroke, Vol. 47, Núm. 3, pp. 863-865

2015

  1. Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury

    Blood, Vol. 126, Núm. 7, pp. 915-919

  2. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study

    Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148

  3. Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant

    Thrombosis and Haemostasis, Vol. 114, Núm. 5, pp. 1038-1048

2014

  1. Group V secretory phospholipase A2 impairs endothelial protein C receptor-dependent protein C activation and accelerates thrombosis in vivo

    Journal of Thrombosis and Haemostasis, Vol. 12, Núm. 11, pp. 1921-1927

  2. Laparoscopic limited liver resection decreases morbidity irrespective of the hepatic segment resected

    HPB, Vol. 16, Núm. 4, pp. 320-326

  3. Lesiones gastrointestinales y características de las hemorragias digestivas agudas en los pacientes anticoagulados con acenocumarol

    Gastroenterologia y Hepatologia, Vol. 37, Núm. 6, pp. 334-341

2013

  1. High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients

    Thrombosis and Haemostasis, Vol. 110, Núm. 1, pp. 184-190

  2. Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients

    Diabetologia, Vol. 56, Núm. 12, pp. 2743-2752

2012

  1. Activated protein C: Reasons to believe

    Journal of Thrombosis and Haemostasis

  2. Atrial fibrillation in pigs induces left atrial endocardial transcriptional remodelling

    Thrombosis and Haemostasis, Vol. 108, Núm. 4, pp. 742-749

  3. Is EPCR a multi-ligand receptor? Pros and cons

    Thrombosis and Haemostasis, Vol. 107, Núm. 5, pp. 815-826